GR Burmester
- Rheumatology top 5%
- Immunology top 10%
- Radiology, Nuclear Medicine and Imaging
- Oncology
- Endocrinology, Diabetes and Metabolism
- Co-authors
- Thomas DörnerFalk HiepeAnnett M. JacobiAndreas RadbruchKarl EgererUte RohrBimba F. HoyerHenrik E. Mei
- Topics
- Rheumatoid Arthritis Research and Therapies (18 papers)Systemic Lupus Erythematosus Research (12 papers)Chronic Lymphocytic Leukemia Research (5 papers)
- Cited by
- RheumatologyImmunologyPeriodontics
- Partner nations
- GermanyUnited StatesPoland
In The Last Decade
GR Burmester
26 papers receiving 480 citations
Peers
Comparison fields: 5 of 65
- Rheumatology 310
- Immunology 248
- Radiology, Nuclear Medicine and Imaging 66
- Oncology 54
- Endocrinology, Diabetes and Metabolism 52
Countries citing papers authored by GR Burmester
This map shows the geographic impact of GR Burmester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by GR Burmester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites GR Burmester more than expected).
Fields of papers citing papers by GR Burmester
This network shows the impact of papers produced by GR Burmester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by GR Burmester. The network helps show where GR Burmester may publish in the future.
Co-authorship network of co-authors of GR Burmester
This figure shows the co-authorship network connecting the top 25 collaborators of GR Burmester. A scholar is included among the top collaborators of GR Burmester based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with GR Burmester. GR Burmester is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Cardiovascular safety - Update from up to 6 years of treatment with baricitinib in rheumatoid arthritis clinical trials | 2 |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 3 | |
| 7 | Methotrexate treatment in large vessel vasculitis and polymyalgia rheumatica. | 19 |
| 8 | 132 | |
| 9 | 36 | |
| 10 | 23 | |
| 11 | Combination treatment with infliximab and leflunomide in patients with active rheumatoid arthritis: safety and efficacy in an open-label clinical trial. | 9 |
| 12 | 1 | |
| 13 | 35 | |
| 14 | 10 | |
| 15 | Improved quality of life with rituximab plus methotrexate in patients with active rheumatoid arthritis who experienced inadequate response to one or more anti-TNF alpha therapies | 7 |
| 16 | 3 | |
| 17 | 1 | |
| 18 | 1 | |
| 19 | 1 | |
| 20 | 66 |
About GR Burmester
GR Burmester is a scholar working on Rheumatology, Immunology and Genetics, having authored 28 papers that have together received 495 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (18 papers), Systemic Lupus Erythematosus Research (12 papers) and Chronic Lymphocytic Leukemia Research (5 papers). The work is most often cited by research in Rheumatology (310 citations), Immunology (248 citations) and Periodontics (28 citations). GR Burmester has collaborated with scholars based in Germany, United States and Poland. Frequent co-authors include Thomas Dörner, Falk Hiepe, Annett M. Jacobi, Andreas Radbruch, Karl Egerer, Ute Rohr, Bimba F. Hoyer, Henrik E. Mei, K. Thiele and Imtiaz M Mumtaz. Their work appears in journals such as Annals of the Rheumatic Diseases, Arthritis Research & Therapy and Value in Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.